Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | MGAM | O43451 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | SI | P14410 | 1/20 | 0.31 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.31 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6066783 | 0.85 | THRB (0.35) | THRBALDH1A1MGAMGAASI | |
| SCHEMBL6067457 | 0.83 | THRB (0.36) | THRBALDH1A1MGAMGAASI | |
| SCHEMBL6066883 | 0.81 | ALDH1A1 (0.38) | ALDH1A1TGFBR1 | |
| SCHEMBL11128147 | 0.81 | ACHE (0.33) | THRB | |
| SCHEMBL25388302 | 0.80 | KDM4E (0.34) | THRB | |
| SCHEMBL25388563 | 0.78 | KDM4E (0.37) | — | |
| SCHEMBL25386373 | 0.78 | KDM4E (0.37) | — | |
| SCHEMBL2461687 | 0.75 | ALOX15 (0.34) | ALDH1A1MGAMGAASIMGAM2 | |
| SCHEMBL477439 | 0.75 | EPHX1 (0.39) | MGAMGAASIMGAM2 | |
| SCHEMBL29440665 | 0.74 | THRB (0.35) | THRBALDH1A1MGAMGAASI |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250179251-A1 | COMPOSITION COMPRISING METHACRYLAMIDE GROUP-CONTAINING ORGANIC SILICON COMPOUND AND ARTICLE SURFACE-TREATED WITH SAID COMPOSITION | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2025-06-05 | — | — | US | disclosed |
| WO-2006087079-A1 | COMPOSITIONS CURED BY MICHAEL ADDITION REACTION | Consortium für elektrochemische Industrie GmbH (DE) | 2006-08-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250179251-A1 | COMPOSITION COMPRISING METHACRYLAMIDE GROUP-CONTAINING ORGANIC SILICON COMPOUND AND ARTICLE SURFACE-TREATED WITH SAID COMPOSITION | CHRM1, CHRM2, CD68 | THRB 1858/4885ALDH1A1 2154/4885MGAM 1411/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.